Pharvaris (PHVS) Cash from Operations (2020 - 2026)

Pharvaris (PHVS) reported Cash from Operations of 57092530.86 for Q1 2026, down 41.08% on a YoY basis from 96901332.11 in Q1 2025, and down 29.23% quarter-over-quarter from 44178661.81 in Q4 2025.

Pharvaris (PHVS) Cash from Operations (2020 - 2026) Analysis & Trends

Pharvaris has reported Cash from Operations for 7 years, with the latest figure at 57092530.86 in Q1 2026.

  • For the quarter ending Q1 2026, Cash from Operations fell 41.08% year-over-year to 57092530.86; the trailing twelve-month figure through Mar 2026 stood at 2539079577625.18 (up 129.3% YoY), and the FY2025 full-year result was 154867325.53, down 19.11% from the prior year.
  • Cash from Operations for Q1 2026 stood at 57092530.86, down from 44178661.81 in the prior quarter.
  • The five-year high for Cash from Operations was 80023999980396.0 in Q3 2025, with the low at 77484819131578.14 in Q2 2025.
  • Historically, Cash from Operations has averaged 213583959260.49 across 5 years, with a median of 26324513.02 in 2024.
  • The largest YoY upside for Cash from Operations was 324922255.76% in 2023 against a maximum downside of 340632884.32% in 2023.
  • Pharvaris' Cash from Operations stood at 20826281.92 in 2022, then fell by 23.0% to 25616942.47 in 2023, then slumped by 45.81% to 37351343.8 in 2024, then fell by 18.28% to 44178661.81 in 2025, then fell by 29.23% to 57092530.86 in 2026.
  • The last three Cash from Operations figures came in at 57092530.86 (Q1 2026), 44178661.81 (Q4 2025), and 80023999980396.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -1.67 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -12.20 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -2.49 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 1.43 Bn
9 Abivax 90.15 Bn 90.15 Bn - -
10 Pharvaris 28.66 Bn 28.37 Bn - -57.09 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -57.09 Mn
Mar 31, 2026 -57.09 Mn
Dec 31, 2025 -44.18 Mn
Dec 31, 2025 -44.18 Mn
Sep 30, 2025 80,024.00 Bn
Sep 30, 2025 80,024.00 Bn
Jun 30, 2025 -77,484.82 Bn
Jun 30, 2025 -77,484.82 Bn
Mar 31, 2025 -40.47 Mn
Mar 31, 2025 -40.47 Mn
Dec 31, 2024 -37.35 Mn
Dec 31, 2024 -37.35 Mn
Sep 30, 2024 57,013.95 Bn
Sep 30, 2024 57,013.95 Bn
Jun 30, 2024 -55,906.57 Bn
Jun 30, 2024 -55,906.57 Bn
Mar 31, 2024 -26.32 Mn
Mar 31, 2024 -26.32 Mn
Dec 31, 2023 -25.62 Mn
Dec 31, 2023 -25.62 Mn